Julian S Gangolli - Net Worth and Insider Trading

Julian S Gangolli Net Worth

The estimated net worth of Julian S Gangolli is at least $23 Million dollars as of 2024-03-29. Julian S Gangolli is the President, North America of GW Pharmaceuticals PLC and owns about 106,548 shares of GW Pharmaceuticals PLC (GWPH) stock worth over $23 Million. Julian S Gangolli is also the CVP & Pres, North America of Allergan PLC and owns about 0 shares of Allergan PLC (AGN) stock worth over $0. Details can be seen in Julian S Gangolli's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Julian S Gangolli has not made any transactions after 2019-05-10 and currently still holds the listed stock(s).

Transaction Summary of Julian S Gangolli

To

Julian S Gangolli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Julian S Gangolli owns 4 companies in total, including Outlook Therapeutics Inc () , Krystal Biotech Inc () , and Revance Therapeutics Inc () among others .

Click here to see the complete history of Julian S Gangolli’s form 4 insider trades.

Insider Ownership Summary of Julian S Gangolli

Ticker Comapny Transaction Date Type of Owner
Outlook Therapeutics Inc 2020-04-20 director
Krystal Biotech Inc 2020-06-30 director
Revance Therapeutics Inc 2016-07-01 director
GW Pharmaceuticals PLC 2019-05-10 President & North America

Julian S Gangolli Latest Holdings Summary

Julian S Gangolli currently owns a total of 2 stocks. Among these stocks, Julian S Gangolli owns 106,548 shares of GW Pharmaceuticals PLC (GWPH) as of May 10, 2019, with a value of $23 Million and a weighting of 100%. Julian S Gangolli also owns 0 shares of Allergan PLC (AGN) as of December 27, 2013, with a value of $0 and a weighting of 0%.

Latest Holdings of Julian S Gangolli

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GWPH GW Pharmaceuticals PLC 2019-05-10 106,548 218.96 23,329,750
AGN Allergan PLC 2013-12-27 0 193.02 0

Holding Weightings of Julian S Gangolli


Julian S Gangolli Form 4 Trading Tracker

According to the SEC Form 4 filings, Julian S Gangolli has made a total of 1 transactions in GW Pharmaceuticals PLC (GWPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in GW Pharmaceuticals PLC is the sale of 671,928 shares on May 10, 2019, which brought Julian S Gangolli around $10 Million.

According to the SEC Form 4 filings, Julian S Gangolli has made a total of 0 transactions in Allergan PLC (AGN) over the past 5 years. The most-recent trade in Allergan PLC is the sale of 52,500 shares on December 27, 2013, which brought Julian S Gangolli around $6 Million.

Insider Trading History of Julian S Gangolli

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Julian S Gangolli Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Julian S Gangolli Ownership Network

Ownership Network List of Julian S Gangolli

No Data

Ownership Network Relation of Julian S Gangolli


Julian S Gangolli Owned Company Details

What does Outlook Therapeutics Inc do?

Who are the key executives at Outlook Therapeutics Inc?

Julian S Gangolli is the director of Outlook Therapeutics Inc. Other key executives at Outlook Therapeutics Inc include Chief Commercial Officer Jeff Evanson , Chief Operating Officer Terry Dagnon , and director & CEO and President Trenary C Russell Iii .

Outlook Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Julian S Gangolli made no insider transaction in Outlook Therapeutics Inc (). Other recent insider transactions involving Outlook Therapeutics Inc () include a net sale of 368,671 shares made by Jeff Evanson , a net purchase of 200,000 shares made by Kurt J Hilzinger , and a net sale of 520,000 shares made by Terry Dagnon .

In summary, during the past 3 months, insiders sold 0 shares of Outlook Therapeutics Inc () in total and bought 3,124 shares, with a net purchase of 3,124 shares. During the past 18 months, 47,558 shares of Outlook Therapeutics Inc () were sold and 16,291 shares were bought by its insiders, resulting in a net sale of 31,266 shares.

Outlook Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Outlook Therapeutics Inc Insider Transactions

No Available Data

Julian S Gangolli Mailing Address

Above is the net worth, insider trading, and ownership report for Julian S Gangolli. You might contact Julian S Gangolli via mailing address: 4955 Baseline Avenue, Santa Ynez Ca 93460.

Discussions on Julian S Gangolli

No discussions yet.